dr reddy's glp-1 drugs portfolio 2025 With the launch of our oral semaglutide biosimilar, Obeda® tablets, we are broadening our GLP‑1 to offer more choice and flexibility for patients. Oral semaglutide, as a convenient and flexible option Dr Reddy’s Steps Up Biosimilars

Foods rich in vitamin A, like carrots, sweet potatoes, and spinach, contribute to a balanced diet that supports melanin reduction naturally

Review: Improving Therapeutics for COVID-19 with Glutathione-boosting Treatments that Improve Immune Responses and Reduce the Severity of Viral Infections Glutathione-boosting treatments can enhance the immune response and reduce the severity of some diseases

Due to their high perfusion rate and excretory role, the kidneys are particularly vulnerable to injury from exogenous toxins, including therapeutic drugs [2]

The battle of probiotics and their derivatives against biofilms

Booster Injections & IV infusions

Probiotics and antimicrobial proteins